DOXOrubicin HCl liposome 50 MG in 25 ML Injection
- RxCUI
- 1790127
- RxNorm name
- DOXOrubicin HCl liposome 50 MG in 25 ML Injection
- Display name
- DOXOrubicin HCl liposome 50 MG in 25 ML Injection
- Full name
- DOXOrubicin HCl liposome 50 MG in 25 ML Injection
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:29
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| doxorubicin hydrochloride | DOXORUBICIN HYDROCHLORIDE | BluePoint Laboratories | 55889588-c5f1-d9bc-e063-6294a90a5791 | 2026-07-09 | Boxed warning, Warnings, Adverse reactions | 1790127 |
| Doxorubicin Hydrochloride | DOXORUBICIN HYDROCHLORIDE | BluePoint Laboratories | f6508535-e7a7-4e50-8d0c-43deda8d0d08 | 2026-05-21 | Boxed warning, Warnings, Adverse reactions | 1790127 |
| Doxorubicin Hydrochloride | DOXORUBICIN HYDROCHLORIDE | NorthStar RxLLC | ddf55319-bf62-4ec7-8be2-ef97188837c4 | 2026-04-10 | Boxed warning, Warnings, Adverse reactions | 1790127 |
| Doxorubicin Hydrochloride | DOXORUBICIN HYDROCHLORIDE | Sun Pharmaceutical Industries, Inc. | fbc48fa5-0bfb-4957-b13c-a56bb7a13b56 | 2026-04-06 | Boxed warning, Warnings, Adverse reactions | 1790127 |
| DOXORUBICIN HYDROCHLORIDE | DOXORUBICIN HYDROCHLORIDE | BluePoint Laboratories | ada390ce-50ea-4de5-be58-5b03caf33c23 | 2026-03-27 | Boxed warning, Warnings, Adverse reactions | 1790127 |
| DOXORUBICIN HYDROCHLORIDE | DOXORUBICIN HYDROCHLORIDE | Zydus Pharmaceuticals USA Inc. | 15a84bd6-b565-4722-bb92-e4c919620a90 | 2026-03-17 | Boxed warning, Warnings, Adverse reactions | 1790127 |
| DOXIL | DOXORUBICIN HYDROCHLORIDE | Baxter Healthcare Corporation | 917eddf9-1d3f-4abe-8c81-d33b066e5bae | 2026-03-10 | Boxed warning, Warnings, Adverse reactions | 1790127 |
| Doxorubicin Hydrochloride Liposome | DOXORUBICIN HYDROCHLORIDE | Sagent Pharmaceuticals | c8eb4784-36e0-483f-9e5d-af0552e49bb5 | 2026-02-24 | Boxed warning, Warnings, Adverse reactions | 1790127 |
| DOXORUBICIN HYDROCHLORIDE | DOXORUBICIN HYDROCHLORIDE | Lupin Pharmaceuticals, Inc. | 0f8eb9a1-74d0-47fd-94b8-a65b29006521 | 2025-11-30 | Boxed warning, Warnings, Adverse reactions | 1790127 |
| doxorubicin hydrochloride | DOXORUBICIN HYDROCHLORIDE | Dr. Reddy's Laboratories Inc. | 0885dddf-727e-4692-92dd-a26c69cc278d | 2025-11-29 | Boxed warning, Warnings, Adverse reactions | 1790127 |
| doxorubicin hydrochloride | DOXORUBICIN HYDROCHLORIDE | Alembic Pharmaceuticals Inc. | c9cb8a8d-944f-4fe1-bfba-c55904a79fda | 2025-07-01 | Boxed warning, Warnings, Adverse reactions | 1790127 |
| doxorubicin hydrochloride | DOXORUBICIN HYDROCHLORIDE | Alembic Pharmaceuticals Limited | f8e001f5-441c-47cd-86f6-5d5e3de16bc0 | 2025-07-01 | Boxed warning, Warnings, Adverse reactions | 1790127 |
| DOXORUBICIN HYDROCHLORIDE | DOXORUBICIN HYDROCHLORIDE | BluePoint Laboratories | b8b66e93-0813-4876-b291-8d7c36a99807 | 2024-12-11 | Boxed warning, Warnings, Adverse reactions | 1790127 |
| Doxorubicin Hydrochloride | DOXORUBICIN HYDROCHLORIDE | Gland Pharma Limited | 74b14803-afc8-4a2e-ba92-43f1a72025eb | 2024-09-24 | Boxed warning, Warnings, Adverse reactions | 1790127 |
| DOXORUBICIN HYDROCHLORIDE | DOXORUBICIN HYDROCHLORIDE | Zydus Lifesciences Limited | bad467d4-7e27-4eda-b4d3-854460f0adab | 2022-11-01 | 1790127 | |
| Doxorubicin Hydrochloride | DOXORUBICIN HYDROCHLORIDE | BluePoint Laboratories | f1a12eb5-5bdc-45f4-843e-0c971535b184 | 2022-09-28 | Boxed warning, Warnings, Adverse reactions | 1790127 |
| DOXIL | DOXORUBICIN HYDROCHLORIDE | Baxter Healthcare Company | 1c153e9e-4cf2-4ac7-9cf9-16f9b48d7dce | 2022-05-31 | Boxed warning, Warnings, Adverse reactions | 1790127 |
| Doxorubicin Hydrochloride Liposome | DOXORUBICIN HYDROCHLORIDE LIPOSOME | Baxter Healthcare Company | cf25a018-e795-49e4-8533-a581f8366dd9 | 2022-05-31 | Boxed warning, Warnings, Adverse reactions | 1790127 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| fbc48fa5-0bfb-4957-b13c-a56bb7a13b56 | 25 ML doxorubicin hydrochloride liposome 2 MG/ML Injection | SCD | 24 | These highlights do not include all the information needed to use DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION safely and effectively. See full prescribing information for DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION. DOXORUBICIN HYDROCHLORIDE liposome injection, for intravenous use Initial U.S. Approval: 1995 | 20260406 |
| fbc48fa5-0bfb-4957-b13c-a56bb7a13b56 | doxorubicin hydrochloride liposome 50 MG per 25 ML Injection | SY | 24 | These highlights do not include all the information needed to use DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION safely and effectively. See full prescribing information for DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION. DOXORUBICIN HYDROCHLORIDE liposome injection, for intravenous use Initial U.S. Approval: 1995 | 20260406 |
| fbc48fa5-0bfb-4957-b13c-a56bb7a13b56 | DOXOrubicin HCl liposome 50 MG in 25 ML Injection | PSN | 24 | These highlights do not include all the information needed to use DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION safely and effectively. See full prescribing information for DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION. DOXORUBICIN HYDROCHLORIDE liposome injection, for intravenous use Initial U.S. Approval: 1995 | 20260406 |
| 74b14803-afc8-4a2e-ba92-43f1a72025eb | doxorubicin hydrochloride liposome 50 MG per 25 ML Injection | SY | 12 | These highlights do not include all the information needed to use DOXORUBICIN HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for DOXORUBICIN HYDROCHLORIDE INJECTION. DOXORUBICIN HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 1974 | 20240924 |
| 74b14803-afc8-4a2e-ba92-43f1a72025eb | 25 ML doxorubicin hydrochloride liposome 2 MG/ML Injection | SCD | 12 | These highlights do not include all the information needed to use DOXORUBICIN HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for DOXORUBICIN HYDROCHLORIDE INJECTION. DOXORUBICIN HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 1974 | 20240924 |
| 74b14803-afc8-4a2e-ba92-43f1a72025eb | DOXOrubicin HCl liposome 50 MG in 25 ML Injection | PSN | 12 | These highlights do not include all the information needed to use DOXORUBICIN HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for DOXORUBICIN HYDROCHLORIDE INJECTION. DOXORUBICIN HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 1974 | 20240924 |
| cf25a018-e795-49e4-8533-a581f8366dd9 | 25 ML doxorubicin hydrochloride liposome 2 MG/ML Injection | SCD | 10 | These highlights do not include all the information needed to use DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION safely and effectively. See full prescribing information for Doxorubicin hydrochloride liposome injection. Doxorubicin Hydrochloride Liposome Injection, for intravenous use Initial U.S. Approval: 1995 | 20220531 |
| cf25a018-e795-49e4-8533-a581f8366dd9 | DOXOrubicin HCl liposome 50 MG in 25 ML Injection | PSN | 10 | These highlights do not include all the information needed to use DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION safely and effectively. See full prescribing information for Doxorubicin hydrochloride liposome injection. Doxorubicin Hydrochloride Liposome Injection, for intravenous use Initial U.S. Approval: 1995 | 20220531 |
| cf25a018-e795-49e4-8533-a581f8366dd9 | doxorubicin hydrochloride liposome 50 MG per 25 ML Injection | SY | 10 | These highlights do not include all the information needed to use DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION safely and effectively. See full prescribing information for Doxorubicin hydrochloride liposome injection. Doxorubicin Hydrochloride Liposome Injection, for intravenous use Initial U.S. Approval: 1995 | 20220531 |
| f5910862-f565-a685-2f3e-9d6e676c381b | DOXOrubicin HCl liposome 50 MG in 25 ML Injection | PSN | 9 | These highlights do not include all the information needed to use DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION safely and effectively. See full prescribing information forDOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION. DOXORUBICIN HYDROCHLORIDE liposome injection, for intravenous use Initial U.S. Approval: 1995 | 20220701 |
| f5910862-f565-a685-2f3e-9d6e676c381b | doxorubicin hydrochloride liposome 50 MG per 25 ML Injection | SY | 9 | These highlights do not include all the information needed to use DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION safely and effectively. See full prescribing information forDOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION. DOXORUBICIN HYDROCHLORIDE liposome injection, for intravenous use Initial U.S. Approval: 1995 | 20220701 |
| f5910862-f565-a685-2f3e-9d6e676c381b | 25 ML doxorubicin hydrochloride liposome 2 MG/ML Injection | SCD | 9 | These highlights do not include all the information needed to use DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION safely and effectively. See full prescribing information forDOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION. DOXORUBICIN HYDROCHLORIDE liposome injection, for intravenous use Initial U.S. Approval: 1995 | 20220701 |
| ddf55319-bf62-4ec7-8be2-ef97188837c4 | DOXOrubicin HCl liposome 50 MG in 25 ML Injection | PSN | 8 | These highlights do not include all the information needed to use DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION safely and effectively. See full prescribing information for DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION. DOXORUBICIN HYDROCHLORIDE liposome injection, for intravenous use Initial U.S. Approval: 1995 | 20260410 |
| ddf55319-bf62-4ec7-8be2-ef97188837c4 | doxorubicin hydrochloride liposome 50 MG per 25 ML Injection | SY | 8 | These highlights do not include all the information needed to use DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION safely and effectively. See full prescribing information for DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION. DOXORUBICIN HYDROCHLORIDE liposome injection, for intravenous use Initial U.S. Approval: 1995 | 20260410 |
| ddf55319-bf62-4ec7-8be2-ef97188837c4 | 25 ML doxorubicin hydrochloride liposome 2 MG/ML Injection | SCD | 8 | These highlights do not include all the information needed to use DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION safely and effectively. See full prescribing information for DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION. DOXORUBICIN HYDROCHLORIDE liposome injection, for intravenous use Initial U.S. Approval: 1995 | 20260410 |
| 67417a18-e0f4-c9a0-e152-b8d8dc934af6 | doxorubicin hydrochloride liposome 50 MG per 25 ML Injection | SY | 6 | These highlights do not include all the information needed to use DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION safely and effectively. See full prescribing information for DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION . DOXORUBICIN HYDROCHLORIDE liposome injection, for intravenous use Initial U.S. Approval: 1995 | 20220901 |
| 67417a18-e0f4-c9a0-e152-b8d8dc934af6 | DOXOrubicin HCl liposome 50 MG in 25 ML Injection | PSN | 6 | These highlights do not include all the information needed to use DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION safely and effectively. See full prescribing information for DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION . DOXORUBICIN HYDROCHLORIDE liposome injection, for intravenous use Initial U.S. Approval: 1995 | 20220901 |
| 67417a18-e0f4-c9a0-e152-b8d8dc934af6 | 25 ML doxorubicin hydrochloride liposome 2 MG/ML Injection | SCD | 6 | These highlights do not include all the information needed to use DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION safely and effectively. See full prescribing information for DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION . DOXORUBICIN HYDROCHLORIDE liposome injection, for intravenous use Initial U.S. Approval: 1995 | 20220901 |
| f6508535-e7a7-4e50-8d0c-43deda8d0d08 | DOXOrubicin HCl liposome 50 MG in 25 ML Injection | PSN | 5 | These highlights do not include all the information needed to use DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION safely and effectively. See full prescribing information for DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION. DOXORUBICIN HYDROCHLORIDE liposome injection, for intravenous use Initial U.S. Approval: 1995 | 20260521 |
| f6508535-e7a7-4e50-8d0c-43deda8d0d08 | 25 ML doxorubicin hydrochloride liposome 2 MG/ML Injection | SCD | 5 | These highlights do not include all the information needed to use DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION safely and effectively. See full prescribing information for DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION. DOXORUBICIN HYDROCHLORIDE liposome injection, for intravenous use Initial U.S. Approval: 1995 | 20260521 |
| f6508535-e7a7-4e50-8d0c-43deda8d0d08 | doxorubicin hydrochloride liposome 50 MG per 25 ML Injection | SY | 5 | These highlights do not include all the information needed to use DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION safely and effectively. See full prescribing information for DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION. DOXORUBICIN HYDROCHLORIDE liposome injection, for intravenous use Initial U.S. Approval: 1995 | 20260521 |
| 15a84bd6-b565-4722-bb92-e4c919620a90 | doxorubicin hydrochloride liposome 50 MG per 25 ML Injection | SY | 5 | These highlights do not include all the information needed to use DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION safely and effectively. See full prescribing information for DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION. DOXORUBICIN HYDROCHLORIDE LIPOSOME injection, for intravenous use Initial U.S. Approval: 1995 | 20260317 |
| 15a84bd6-b565-4722-bb92-e4c919620a90 | DOXOrubicin HCl liposome 50 MG in 25 ML Injection | PSN | 5 | These highlights do not include all the information needed to use DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION safely and effectively. See full prescribing information for DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION. DOXORUBICIN HYDROCHLORIDE LIPOSOME injection, for intravenous use Initial U.S. Approval: 1995 | 20260317 |
| 15a84bd6-b565-4722-bb92-e4c919620a90 | 25 ML doxorubicin hydrochloride liposome 2 MG/ML Injection | SCD | 5 | These highlights do not include all the information needed to use DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION safely and effectively. See full prescribing information for DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION. DOXORUBICIN HYDROCHLORIDE LIPOSOME injection, for intravenous use Initial U.S. Approval: 1995 | 20260317 |
| 917eddf9-1d3f-4abe-8c81-d33b066e5bae | doxorubicin hydrochloride liposome 50 MG per 25 ML Injection | SY | 5 | These highlights do not include all the information needed to use DOXIL safely and effectively. See full prescribing information for DOXIL. DOXIL (doxorubicin hydrochloride liposome injection), for intravenous use Initial U.S. Approval: 1995 | 20260310 |
| 917eddf9-1d3f-4abe-8c81-d33b066e5bae | 25 ML doxorubicin hydrochloride liposome 2 MG/ML Injection | SCD | 5 | These highlights do not include all the information needed to use DOXIL safely and effectively. See full prescribing information for DOXIL. DOXIL (doxorubicin hydrochloride liposome injection), for intravenous use Initial U.S. Approval: 1995 | 20260310 |
| 917eddf9-1d3f-4abe-8c81-d33b066e5bae | DOXOrubicin HCl liposome 50 MG in 25 ML Injection | PSN | 5 | These highlights do not include all the information needed to use DOXIL safely and effectively. See full prescribing information for DOXIL. DOXIL (doxorubicin hydrochloride liposome injection), for intravenous use Initial U.S. Approval: 1995 | 20260310 |
| 0f8eb9a1-74d0-47fd-94b8-a65b29006521 | DOXOrubicin HCl liposome 50 MG in 25 ML Injection | PSN | 4 | These highlights do not include all the information needed to use DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION safely and effectively. See full prescribing information for DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION. DOXORUBICIN HYDROCHLORIDE liposome injection, for intravenous use Initial U.S. Approval: 1995 | 20251130 |
| 0f8eb9a1-74d0-47fd-94b8-a65b29006521 | 25 ML doxorubicin hydrochloride liposome 2 MG/ML Injection | SCD | 4 | These highlights do not include all the information needed to use DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION safely and effectively. See full prescribing information for DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION. DOXORUBICIN HYDROCHLORIDE liposome injection, for intravenous use Initial U.S. Approval: 1995 | 20251130 |
| 0f8eb9a1-74d0-47fd-94b8-a65b29006521 | doxorubicin hydrochloride liposome 50 MG per 25 ML Injection | SY | 4 | These highlights do not include all the information needed to use DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION safely and effectively. See full prescribing information for DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION. DOXORUBICIN HYDROCHLORIDE liposome injection, for intravenous use Initial U.S. Approval: 1995 | 20251130 |
| c9cb8a8d-944f-4fe1-bfba-c55904a79fda | DOXOrubicin HCl liposome 50 MG in 25 ML Injection | PSN | 4 | These highlights do not include all the information needed to use DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION safely and effectively. See full prescribing information for DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION. DOXORUBICIN HYDROCHLORIDE liposome injection, for intravenous use Initial U.S. Approval: 1995 | 20250701 |
| c9cb8a8d-944f-4fe1-bfba-c55904a79fda | 25 ML doxorubicin hydrochloride liposome 2 MG/ML Injection | SCD | 4 | These highlights do not include all the information needed to use DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION safely and effectively. See full prescribing information for DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION. DOXORUBICIN HYDROCHLORIDE liposome injection, for intravenous use Initial U.S. Approval: 1995 | 20250701 |
| c9cb8a8d-944f-4fe1-bfba-c55904a79fda | doxorubicin hydrochloride liposome 50 MG per 25 ML Injection | SY | 4 | These highlights do not include all the information needed to use DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION safely and effectively. See full prescribing information for DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION. DOXORUBICIN HYDROCHLORIDE liposome injection, for intravenous use Initial U.S. Approval: 1995 | 20250701 |
| f1a12eb5-5bdc-45f4-843e-0c971535b184 | doxorubicin hydrochloride liposome 50 MG per 25 ML Injection | SY | 4 | These highlights do not include all the information needed to use DOXORUBICIN HYDROCHLORIDELIPOSOME INJECTION safely and effectively. See full prescribing information for DOXORUBICIN HYDROCHLORIDELIPOSOME INJECTION DOXORUBICIN HYDROCHLORIDELIPOSOME INJECTION for intravenous infusion Initial U.S. Approval: 1995 | 20220928 |
| f1a12eb5-5bdc-45f4-843e-0c971535b184 | 25 ML doxorubicin hydrochloride liposome 2 MG/ML Injection | SCD | 4 | These highlights do not include all the information needed to use DOXORUBICIN HYDROCHLORIDELIPOSOME INJECTION safely and effectively. See full prescribing information for DOXORUBICIN HYDROCHLORIDELIPOSOME INJECTION DOXORUBICIN HYDROCHLORIDELIPOSOME INJECTION for intravenous infusion Initial U.S. Approval: 1995 | 20220928 |
| f1a12eb5-5bdc-45f4-843e-0c971535b184 | DOXOrubicin HCl liposome 50 MG in 25 ML Injection | PSN | 4 | These highlights do not include all the information needed to use DOXORUBICIN HYDROCHLORIDELIPOSOME INJECTION safely and effectively. See full prescribing information for DOXORUBICIN HYDROCHLORIDELIPOSOME INJECTION DOXORUBICIN HYDROCHLORIDELIPOSOME INJECTION for intravenous infusion Initial U.S. Approval: 1995 | 20220928 |
| bad467d4-7e27-4eda-b4d3-854460f0adab | 25 ML doxorubicin hydrochloride liposome 2 MG/ML Injection | SCD | 2 | DOXOrubicin Hydrochloride Liposome Injection | 20221101 |
| bad467d4-7e27-4eda-b4d3-854460f0adab | doxorubicin hydrochloride liposome 50 MG per 25 ML Injection | SY | 2 | DOXOrubicin Hydrochloride Liposome Injection | 20221101 |
| bad467d4-7e27-4eda-b4d3-854460f0adab | DOXOrubicin HCl liposome 50 MG in 25 ML Injection | PSN | 2 | DOXOrubicin Hydrochloride Liposome Injection | 20221101 |
| ada390ce-50ea-4de5-be58-5b03caf33c23 | DOXOrubicin HCl liposome 50 MG in 25 ML Injection | PSN | 1 | These highlights do not include all the information needed to use DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION safely and effectively. See full prescribing information for DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION. DOXORUBICIN HYDROCHLORIDE LIPOSOME injection, for intravenous use Initial U.S. Approval: 1995 | 20260327 |
| ada390ce-50ea-4de5-be58-5b03caf33c23 | doxorubicin hydrochloride liposome 50 MG per 25 ML Injection | SY | 1 | These highlights do not include all the information needed to use DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION safely and effectively. See full prescribing information for DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION. DOXORUBICIN HYDROCHLORIDE LIPOSOME injection, for intravenous use Initial U.S. Approval: 1995 | 20260327 |
| ada390ce-50ea-4de5-be58-5b03caf33c23 | 25 ML doxorubicin hydrochloride liposome 2 MG/ML Injection | SCD | 1 | These highlights do not include all the information needed to use DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION safely and effectively. See full prescribing information for DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION. DOXORUBICIN HYDROCHLORIDE LIPOSOME injection, for intravenous use Initial U.S. Approval: 1995 | 20260327 |
| c8eb4784-36e0-483f-9e5d-af0552e49bb5 | doxorubicin hydrochloride liposome 50 MG per 25 ML Injection | SY | 1 | These highlights do not include all the information needed to use DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION safely and effectively. See full prescribing information for DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION. DOXORUBICIN HYDROCHLORIDE LIPOSOME injection, for intravenous use Initial U.S. Approval: 1995 | 20260224 |
| c8eb4784-36e0-483f-9e5d-af0552e49bb5 | DOXOrubicin HCl liposome 50 MG in 25 ML Injection | PSN | 1 | These highlights do not include all the information needed to use DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION safely and effectively. See full prescribing information for DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION. DOXORUBICIN HYDROCHLORIDE LIPOSOME injection, for intravenous use Initial U.S. Approval: 1995 | 20260224 |
| c8eb4784-36e0-483f-9e5d-af0552e49bb5 | 25 ML doxorubicin hydrochloride liposome 2 MG/ML Injection | SCD | 1 | These highlights do not include all the information needed to use DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION safely and effectively. See full prescribing information for DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION. DOXORUBICIN HYDROCHLORIDE LIPOSOME injection, for intravenous use Initial U.S. Approval: 1995 | 20260224 |
| 0885dddf-727e-4692-92dd-a26c69cc278d | doxorubicin hydrochloride liposome 50 MG per 25 ML Injection | SY | 1 | These highlights do not include all the information needed to use DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION safely and effectively. See full prescribing information for DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION. DOXORUBICIN HYDROCHLORIDE liposome injection, for intravenous use Initial U.S. Approval: 1995 | 20251129 |
| 0885dddf-727e-4692-92dd-a26c69cc278d | DOXOrubicin HCl liposome 50 MG in 25 ML Injection | PSN | 1 | These highlights do not include all the information needed to use DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION safely and effectively. See full prescribing information for DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION. DOXORUBICIN HYDROCHLORIDE liposome injection, for intravenous use Initial U.S. Approval: 1995 | 20251129 |
| 0885dddf-727e-4692-92dd-a26c69cc278d | 25 ML doxorubicin hydrochloride liposome 2 MG/ML Injection | SCD | 1 | These highlights do not include all the information needed to use DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION safely and effectively. See full prescribing information for DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION. DOXORUBICIN HYDROCHLORIDE liposome injection, for intravenous use Initial U.S. Approval: 1995 | 20251129 |
| f8e001f5-441c-47cd-86f6-5d5e3de16bc0 | doxorubicin hydrochloride liposome 50 MG per 25 ML Injection | SY | 1 | These highlights do not include all the information needed to use DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION safely and effectively. See full prescribing information for DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION. DOXORUBICIN HYDROCHLORIDE liposome injection, for intravenous use Initial U.S. Approval: 1995 | 20250701 |
| f8e001f5-441c-47cd-86f6-5d5e3de16bc0 | DOXOrubicin HCl liposome 50 MG in 25 ML Injection | PSN | 1 | These highlights do not include all the information needed to use DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION safely and effectively. See full prescribing information for DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION. DOXORUBICIN HYDROCHLORIDE liposome injection, for intravenous use Initial U.S. Approval: 1995 | 20250701 |
| f8e001f5-441c-47cd-86f6-5d5e3de16bc0 | 25 ML doxorubicin hydrochloride liposome 2 MG/ML Injection | SCD | 1 | These highlights do not include all the information needed to use DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION safely and effectively. See full prescribing information for DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION. DOXORUBICIN HYDROCHLORIDE liposome injection, for intravenous use Initial U.S. Approval: 1995 | 20250701 |
| b8b66e93-0813-4876-b291-8d7c36a99807 | doxorubicin hydrochloride liposome 50 MG per 25 ML Injection | SY | 1 | These highlights do not include all the information needed to use DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION safely and effectively. See full prescribing information for DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION. DOXORUBICIN HYDROCHLORIDE liposome injection, for intravenous use Initial U.S. Approval: 1995 | 20241211 |
| b8b66e93-0813-4876-b291-8d7c36a99807 | 25 ML doxorubicin hydrochloride liposome 2 MG/ML Injection | SCD | 1 | These highlights do not include all the information needed to use DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION safely and effectively. See full prescribing information for DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION. DOXORUBICIN HYDROCHLORIDE liposome injection, for intravenous use Initial U.S. Approval: 1995 | 20241211 |
| b8b66e93-0813-4876-b291-8d7c36a99807 | DOXOrubicin HCl liposome 50 MG in 25 ML Injection | PSN | 1 | These highlights do not include all the information needed to use DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION safely and effectively. See full prescribing information for DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION. DOXORUBICIN HYDROCHLORIDE liposome injection, for intravenous use Initial U.S. Approval: 1995 | 20241211 |